Article
PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker.
Cell death & disease - 25 Apr 2024
Ou Xiaomin, Zhang Yingzi, Xu Yiqing, Liu Yi, Tu Wenzhi, Hu Chaosu, Liu Yong
Abstract excerpt
Although many important advances have been made in the treatment of nasopharyngeal carcinoma (NPC) in recent years, local recurrence and distant metastasis remain the main factors affecting NPC prognosis. Biomarkers for predicting the prognosis of NPC need to be urgently identified. Here, we used whole-exon sequencing (WES) to determine whether PICK1 mutations are associated with the prognosis of NPC....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
